Background: Neuromyelitis optica (NMO) is a disease with autoimmune characteristics. A genetic autoimmune dependency for NMO has not been clarified in detail.
Objective: To investigate immunogenetic aspects of NMO.
Methods: Forty-one patients with NMO and 42 patients with multiple sclerosis (MS) were diagnosed in a population-based Caucasian cohort. HLA DQA1, DQB1, and DRB1 alleles were determined. Polymorphisms in programmed death 1 (PD-1) PD-1.3 G/A and protein tyrosine phosphatase non-receptor 22 (PTPN22) 1858 C/T were genotyped.
Results: In the NMO group 15% had other autoimmune disorders and 39% had family occurrence of autoimmunity, comparable to MS. A higher frequency of a family history (17%) of NMO and MS was found in the NMO group (p < 0.026). The frequency of HLA-DQB1*0402 allele was increased in NMO (p after Bonferroni correction, cp < 0.035) and the HLA-DRB1*15 and DQB1*06 alleles were increased in MS (cp < 0.0027, cp < 0.01), compared to controls. No associations of the PTPN22 1858 T were detected. The PD-1.3A allele was increased both in NMO (p < 0.0023) and in MS patients (p < 0.028) compared to controls.
Conclusion: Patients with NMO had frequent co-existence of autoimmunity and family occurrence of NMO and MS. The PD-1.3A allele was associated with NMO. The data suggest genetic autoimmune dependency of NMO.
LennonVAKryzerTJPittockSJVerkmanASHinsonSR. IgG marker of optic–spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med2005; 202: 473–477.
2.
AsgariNOwensTFrokiaerJStenagerELillevangSTKyvikKO. Neuromyelitis optica (NMO) – an autoimmune disease of the central nervous system (CNS). Acta Neurol Scand2011; 123: 369–384.
3.
WingerchukDMLennonVAPittockSJLucchinettiCFWeinshenkerBG. Revised diagnostic criteria for neuromyelitis optica. Neurology2006; 66: 1485–1489.
4.
LucchinettiCFMandlerRNMcGavernDBruckWGleichGRansohoffRM. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain2002; 125: 1450–1461.
5.
RoemerSFParisiJELennonVABenarrochEELassmannHBruckW. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain2007; 130: 1194–1205.
6.
FernandoMMStevensCRWalshECDe JagerPLGoyettePPlengeRM. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet2008; 4: e1000024.
7.
BrynedalBDuvefeltKJonasdottirGRoosIMAkessonEPalmgrenJ. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE2007; 2: e664.
8.
BarcellosLFOksenbergJRBegovichABMartinERSchmidtSVittinghoffE. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet2003; 72: 710–716.
9.
BrumDGBarreiraAAdos SantosACKaimen-MacielDRMatielloMCostaRM. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Mult Scler2010; 16: 21–29.
10.
ZephirHFajardyIOutteryckOBlancFRogerNFleuryM. Is neuromyelitis optica associated with human leukocyte antigen?Mult Scler2009; 15: 571–579.
11.
DeschampsRPaturelLJeanninSChaussonNOlindoSBeraO. Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population. Mult Scler2011; 17: 24–31.
12.
MatsushitaTMatsuokaTIsobeNKawanoYMinoharaMShiN. Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens2009; 73: 171–176.
PittockSJLennonVAdeSJVermerschPHomburgerHAWingerchukDM. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol2008; 65: 78–83.
15.
BegovichABCarltonVEHonigbergLASchrodiSJChokkalingamAPAlexanderHC. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet2004; 75: 330–337.
16.
KyogokuCLangefeldCDOrtmannWALeeASelbySCarltonVE. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet2004; 75: 504–507.
17.
NielsenCHansenDHusbySLillevangST. Sex-specific association of the human PTPN22 1858-T-allele with type 1 diabetes. Int J Immunogenet2007; 34: 469–473.
18.
VelagaMRWilsonVJenningsCEOwenCJHeringtonSDonaldsonPT. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves’ disease. J Clin Endocrinol Metab2004; 89: 5862–5865.
19.
OkazakiTWangJ. PD-1/PD-L pathway and autoimmunity. Autoimmunity2005; 38: 353–357.
20.
KronerAMehlingMHemmerBRieckmannPToykaKVMaurerM. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol2005; 58: 50–57.
21.
NielsenCLaustrupHVossAJunkerPHusbySLillevangST. A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients. Lupus2004; 13: 510–516.
22.
AsgariNLillevangSTSkejoeHPFalahMStenagerEKyvikKO. A population-based study of neuromyelitis optica in Caucasians. Neurology2011; 76: 1589–1595.
23.
BarkhofFFilippiMMillerDHScheltensPCampiAPolmanCH. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain1997; 120(Pt 11): 2059–2069.
24.
McDonaldWICompstonAEdanGGoodkinDHartungHPLublinFD. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121–127.
25.
WingerchukDMLennonVALucchinettiCFPittockSJWeinshenkerBG. The spectrum of neuromyelitis optica. Lancet Neurol2007; 6: 805–815.
26.
DahlbomIKorponay-SzaboIRKovacsJBSzalaiZMakiMHanssonT. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr2010; 50: 140–146.
ErlichHValdesAMNobleJCarlsonJAVarneyMConcannonP. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes2008; 57: 1084–1092.
29.
SailaHPitkaniemiJTuomilehtoJSavolainenAAlakulppiNTuomilehto-WolfE. HLA and susceptibility to juvenile idiopathic arthritis: a study of affected sibpairs in an isolated Finnish population. JRheumatol2004; 31: 2281–2285.
30.
UnderhillJDonaldsonPBrayGDohertyDPortmannBWilliamsR. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology1992; 16: 1404–1408.
31.
IttahMGottenbergJEProustAHachullaEPuechalXLoiseauP. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjogren’s syndrome. Genes Immun2005; 6: 457–458.
MustelinTAbrahamRTRuddCEAlonsoAMerloJJ. Protein tyrosine phosphorylation in T cell signaling. Front Biosci2002; 7: d918–d969.
34.
BegovichABCaillierSJAlexanderHCPenkoJMHauserSLBarcellosLF. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet2005; 76: 184–187.
35.
RamanujamRZhaoYPirskanenRHammarstromL. Lack of association of the CIITA − 168 A→G promoter SNP with myasthenia gravis and its role in autoimmunity. BMC Med Genet2010; 11: 147.
36.
SharpeAHWherryEJAhmedRFreemanGJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol2007; 8: 239–245.
37.
NishimuraHNoseMHiaiHMinatoNHonjoT. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity1999; 11: 141–151.
38.
WangJYoshidaTNakakiFHiaiHOkazakiTHonjoT. Establishment of NOD-Pdcd1−/− mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci U S A2005; 102: 11823–11828.
39.
WangCLiYProctorTMVandenbarkAAOffnerH. Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis. J Neurosci Res2010Jan; 88: 7–15.
40.
TrabattoniDSaresellaMPaceiM. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. J Immunol2009Oct15; 183: 4984–4993.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
